NCT07761338

Brief Summary

The purpose of the study is to quantify the levels of platelets and inflammatory markers in A-PRF from a standard venous whole blood sample, and to evaluate the effect of A-PRF on postoperative discomfort and complications following surgical removal of M3. The study will be prospective and include 60 patients referred to Specialtandlægerne Vestergade for surgical removal of one M3. It is expected that the study will contribute with important information on the impact of A-PRF on postoperative sequelae and complications following surgical removal of mandibular third molars.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
1.5 years until next milestone

First Posted

Study publicly available on registry

August 12, 2026

Completed
Last Updated

August 12, 2026

Status Verified

September 1, 2024

Enrollment Period

3 months

First QC Date

September 18, 2024

Last Update Submit

August 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Levels of thrombocytes and growth factors in advanced platelet-rich fibrin

    Quantification of thrombocytes and specific growth factors (FGF, TGH-B1, VEGF, PDGF-B) released from advanced platelet-rich fibrin measured in concentration levels

    From enrollment to one week following surgery

Interventions

Third molarPROCEDURE

Evaluate the level of thrombocytes and growth factors in A-PRF and whole blood sample

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Healthy patients with indication for surgical removal of mandibular third molar

You may qualify if:

  • indication for surgical removal of mandibular third molar

You may not qualify if:

  • breastfeading, pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Copenhagen

Copenhagen, Denmark

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Week
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2024

First Posted

August 12, 2026

Study Start

October 1, 2024

Primary Completion

December 31, 2024

Study Completion

January 31, 2025

Last Updated

August 12, 2026

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations